Kovitz Investment Group Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.34M Sell
5,801
-2,538
-30% -$2.57M 0.12% 131
2025
Q4
$8.96M Sell
8,339
-63,568
-88% -$60.8M 0.2% 107
2025
Q3
$54.9M Buy
71,907
+5,192
+8% +$3.86M 0.21% 100
2025
Q2
$52M Buy
66,715
+19,131
+40% +$14.9M 0.22% 100
2025
Q1
$39.3M Buy
47,584
+2,454
+5% +$2.04M 0.2% 104
2024
Q4
$34.8M Sell
45,130
-1,002
-2% -$830K 0.17% 115
2024
Q3
$29.7M Buy
46,132
+24,879
+117% +$22.4M 0.21% 92
2024
Q2
$19.2M Buy
21,253
+2,449
+13% +$1.96M 0.16% 100
2024
Q1
$14.6M Buy
18,804
+1,241
+7% +$883K 0.19% 80
2023
Q4
$10.2M Sell
17,563
-1,730
-9% -$1.01M 0.17% 65
2023
Q3
$10.4M Sell
19,293
-278
-1% -$143K 0.19% 58
2023
Q2
$9.18M Sell
19,571
-5,671
-22% -$2.38M 0.13% 76
2023
Q1
$8.67M Sell
25,242
-6,011
-19% -$2.03M 0.15% 84
2022
Q4
$11.4M Sell
31,253
-6,572
-17% -$2.33M 0.23% 64
2022
Q3
$12.2M Buy
37,825
+1,239
+3% +$393K 0.28% 50
2022
Q2
$11.9M Sell
36,586
-6,239
-15% -$1.87M 0.26% 58
2022
Q1
$12.3M Sell
42,825
-944
-2% -$243K 0.23% 63
2021
Q4
$7.39M Sell
43,769
-8,711
-17% -$2.21M 0.17% 87
2021
Q3
$12.1M Sell
52,480
-1,548
-3% -$382K 0.24% 58
2021
Q2
$12.4M Buy
54,028
+14,942
+38% +$3M 0.24% 56
2021
Q1
$7.3M Sell
39,086
-4,608
-11% -$901K 0.17% 91
2020
Q4
$7.38M Buy
43,694
+4,695
+12% +$701K 0.18% 85
2020
Q3
$5.77M Buy
38,999
+28,658
+277% +$4.44M 0.16% 101
2020
Q2
$1.7M Buy
10,341
+5,694
+123% +$874K 0.05% 195
2020
Q1
$645K Buy
4,647
+938
+25% +$129K 0.02% 278
2019
Q4
$487K Buy
3,709
+39
+1% +$4.52K 0.01% 320
2019
Q3
$410K Sell
3,670
-830
-18% -$92.4K 0.01% 326
2019
Q2
$498K Sell
4,500
-350
-7% -$41.2K 0.02% 309
2019
Q1
$629K Sell
4,850
-200
-4% -$24.3K 0.02% 307
2018
Q4
$584K Sell
5,050
-150
-3% -$16.8K 0.02% 221
2018
Q3
$558K Sell
5,200
-811
-13% -$81.1K 0.03% 110
2018
Q2
$513K Buy
6,011
+61
+1% +$5.01K 0.02% 114
2018
Q1
$460K Sell
5,950
-1,300
-18% -$105K 0.02% 113
2017
Q4
$612 Hold
7,250
0.03% 109
2017
Q3
$620K Hold
7,250
0.03% 108
2017
Q2
$597K Sell
7,250
-200
-3% -$16.3K 0.03% 108
2017
Q1
$627K Buy
7,450
+151
+2% +$12.1K 0.03% 88
2016
Q4
$537K Hold
7,299
0.03% 85
2016
Q3
$586K Buy
7,299
+49
+0.7% +$3.92K 0.04% 92
2016
Q2
$571K Sell
7,250
-6,000
-45% -$452K 0.04% 91
2016
Q1
$954K Buy
+13,250
New +$1M 0.06% 82

Other funds holding LLY

Kovitz Investment Group Partners's LLY Position: Q1 2026 in Review

Kovitz Investment Group Partners reduced its Eli Lilly (LLY) stake by 30% in Q1 2026, selling an estimated $2.57M and leaving 5,801 shares worth $5.34M. The position accounts for 0.12% of the portfolio, ranked #131.

Kovitz Investment Group Partners first reported a position in LLY in Q1 2016 and has held it in 41 quarters since. The position peaked at $54.9M in Q3 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Kovitz Investment Group Partners held 5,801 shares of Eli Lilly worth $5.34M as of Q1 2026.
  • Kovitz Investment Group Partners sold 2,538 Eli Lilly shares in Q1 2026, an estimated $2.57M.
  • Eli Lilly made up 0.12% of Kovitz Investment Group Partners's portfolio in Q1 2026, its #131 holding.
  • Kovitz Investment Group Partners first reported a position in Eli Lilly in Q1 2016 and has held it in 41 quarters since.
  • Kovitz Investment Group Partners's Eli Lilly position peaked at $54.9M in Q3 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Kovitz Investment Group Partners's 13F filing for Q1 2026, filed 13 May 2026.